Inventor
CHUNG JOHN Y L
US29 patents
⚠️ This page may combine multiple inventors who share the name “CHUNG JOHN Y L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
16 patentsUS9822121B2Nov 21, 2017
Process for making beta 3 agonists and intermediates
MERCK SHARP & DOHME13 citations92
US11708371B2Jul 25, 2023
Process for making beta 3 agonists and intermediates
MERCK SHARP & DOHME3 citations83
US11124478B2Sep 21, 2021
Process for making beta 3 agonists and intermediates
MERCK SHARP & DOHME5 citations83
US10899771B2Jan 26, 2021
Process for making beta 3 agonists and intermediates
MERCK SHARP & DOHME7 citations83
US10577316B2Mar 3, 2020
Process for making beta 3 agonists and intermediates
MERCK SHARP & DOHME9 citations83
US10435410B2Oct 8, 2019
Process for making beta 3 agonists and intermediates
MERCK SHARP & DOHME9 citations83
US10087189B2Oct 2, 2018
Process for making beta 3 agonists and intermediates
MERCK SHARP & DOHME10 citations83
US9809536B2Nov 7, 2017
Process for making beta 3 agonists and intermediates
MERCK SHARP & DOHME12 citations83
US11767292B2Sep 26, 2023
Process for making beta 3 agonists and intermediates
MERCK SHARP & DOHME3 citations72
US9012488B2Apr 21, 2015
Crystalline polymorphic forms of an antidiabetic compound
MERCK SHARP & DOHME2 citations59
US10472345B2Nov 12, 2019
Methods of preparing hydroxylamine derivatives useful in the preparation of anti-infective agents
MERCK SHARP & DOHME1 citations56
US9315457B2Apr 19, 2016
Crystalline polymorphic forms of an antidiabetic compound
MERCK SHARP & DOHME0 citations52
US9272999B2Mar 1, 2016
Crystalline polymorphic forms of an antidiabetic compound
MERCK SHARP & DOHME0 citations50
US10053466B2Aug 21, 2018
Process for preparing chiral dipeptidyl peptidase-IV inhibitors
MERCK SHARP & DOHME0 citations49
US9862725B2Jan 9, 2018
Process for preparing chiral dipeptidyl peptidase-IV inhibitors
MERCK SHARP & DOHME0 citations49
US10214554B2Feb 26, 2019
Process for making chloro-substituted nucleoside phosphoramidate compounds
MERCK SHARP & DOHME0 citations42
MERCK & CO INC
8 patentsUS5792871AAug 11, 1998
Process for N-Boc-N-(R)-2(3-pyridyl)-2-hydroxy-ethyl)-N-2(4-aminophenyl)ethyl amine and 2-(4-aminophenyl)-N-2-(2(R)-hydroxy-2-phyridin-S-yl-ethyl)acetamide
MERCK & CO INC17 citations82
US5665882ASep 9, 1997
Pyridyl ethylation of lactams
MERCK & CO INC10 citations73
US5314898AMay 24, 1994
Aryl thiopyrano[4,3,2-cd]indoles as inhibitors of leukotriene biosynthesis
MERCK & CO INC16 citations73
US5312923AMay 17, 1994
Process for preparing fibrinogen receptor antagonists
MERCK & CO INC9 citations73
US5206373AApr 27, 1993
Process for preparing fibrinogen receptor antagonists
MERCK & CO INC6 citations62
US5846791ADec 8, 1998
N-(R)-(2-hydroxy-2-pyridine-3-yl-ethyl)-2-(4-nitro-phenyl)-acetamide
MERCK & CO INC5 citations61
US5686607ANov 11, 1997
Pyridyl ethylation of lactam derivatives
MERCK & CO INC0 citations52
US6620824B2Sep 16, 2003
Process for the synthesis of gonadotropin releasing hormone antagonists
MERCK & CO INC0 citations39
ABBOTT LAB
2 patentsMERCK SHARP & DOHME LLC
2 patentsUS12162883B2Dec 10, 2024
Process for the preparation of intermediates useful for making (2S,5R)-7-oxo-n-piperidin-4-yl-6-(sulfoxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide
MERCK SHARP & DOHME LLC0 citations58
US12391694B2Aug 19, 2025
Process for the preparation of 2-fluoroadenine
MERCK SHARP & DOHME LLC0 citations56